Optimal Use of Antibiotics in Urology

Chapter
First Online:

Abstract

Urinary tract infections (UTI) are one of the most frequent infections and consequently one of the most frequent indications of prescribing antibiotics. Optimal use of antibiotics in these infections is necessary to successfully treat patients as well as combat with increasing resistance. This requires individualization of treatment based on various features of UTIs. Bacterial spectrum, local resistance patterns, key features of urological infections have to be considered in the selection of antimicrobial agents for the treatment of UTIs. Recommendations based on major guidelines and clinical tips will be discussed in this chapter.

Keywords

Urinary Tract Infection Antibiotic Prophylaxis Antimicrobial Prophylaxis Complicated Urinary Tract Infection Chronic Bacterial Prostatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens A. Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol. 2008;54(6):1270–86.CrossRefPubMedGoogle Scholar
  2. 2.
    CDC Sexually Transmitted Diseases Guideline, 2010.Google Scholar
  3. 3.
    Gyssens IC. Antibiotic policy. Int J Antimicrob Agents. 2011;38(Suppl):11–20.CrossRefPubMedGoogle Scholar
  4. 4.
    Grabe M, Bjerklund-Johansen TE, Botto H, et al. Guidelines on urological infections. In: EAU Guidelines, edition presented at the 29th EAU Annual Congress, Stockholm 2014. ISBN 978-90-79754-65- 6. 2.Google Scholar
  5. 5.
    Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the infectious diseases society of America and the European society for microbiology and infectious diseases. IDSA Clinical practice Guidelines CID. Clin Infect Dis. 2011;52:103–20.Google Scholar
  6. 6.
    Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO · SENS study revisited. Int J Antimicrob Agents. 2012;39(1):45–51.CrossRefPubMedGoogle Scholar
  7. 7.
    Paterson DL. “Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis. 2004;38 Suppl 4:S341–5.CrossRefPubMedGoogle Scholar
  8. 8.
    Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, Marchese A. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents. 2009;34(5):407–13.CrossRefPubMedGoogle Scholar
  9. 9.
    Taylor AK, Zembower TR, Nadler RB, et al. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol. 2012;187(4):1275–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Wagenlehner FM, Weidner W, Naber KG. Antibiotics in urology: new essentials. Urol Clin North Am. 2008;35(1):69–79.CrossRefPubMedGoogle Scholar
  11. 11.
    Wagenlehner FM, van Oostrum E, Tenke P, et al. Infective complications after prostate biopsy: outcome of the global prevalence study of infections in urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol. 2013;63(3):521–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Wolf Jr JS, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ, Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy Panel. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol. 2008;179(4):1379–90.CrossRefPubMedGoogle Scholar
  13. 13.
    Zhanel GG, Hisanaga TL, Laing NM, et al. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents. 2005;26(5):380–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2017

Authors and Affiliations

  1. 1.Department of UrologyMedical School, Trakya UniversityEdirneTurkey

Personalised recommendations